About Oslo universitetssykehus HF, Ullevål, Kreftsenteret
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Oslo universitetssykehus HF, Ullevål, Kreftsenteret
During the past decade, Oslo universitetssykehus HF, Ullevål, Kreftsenteret conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Oslo universitetssykehus HF, Ullevål, Kreftsenteret"
#1 collaborator was "Foundation Medicine, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Oslo universitetssykehus HF, Ullevål, Kreftsenteret
According to Clinical.Site data, the most researched conditions in "Oslo universitetssykehus HF, Ullevål, Kreftsenteret" are
"Breast Cancer" (2 trials), "Adenocarcinoma" (1 trials), "Breast Neoplasms" (1 trials), "Bronchial Diseases" (1 trials) and "Cancer of Unknown Primary Site" (1 trials). Many other conditions were trialed in "Oslo universitetssykehus HF, Ullevål, Kreftsenteret" in a lesser frequency.
Clinical Trials Intervention Types at Oslo universitetssykehus HF, Ullevål, Kreftsenteret
Most popular intervention types in "Oslo universitetssykehus HF, Ullevål, Kreftsenteret" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (4 trials), "Pertuzumab" (3 trials), "5-Fluorouracil" (2 trials), "Carboplatin" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Oslo universitetssykehus HF, Ullevål, Kreftsenteret
The vast majority of trials in "Oslo universitetssykehus HF, Ullevål, Kreftsenteret" are
5 trials for "All" genders.
Clinical Trials Status at Oslo universitetssykehus HF, Ullevål, Kreftsenteret
Currently, there are NaN active trials in "Oslo universitetssykehus HF, Ullevål, Kreftsenteret".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Oslo universitetssykehus HF, Ullevål, Kreftsenteret,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Oslo universitetssykehus HF, Ullevål, Kreftsenteret, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".